Sarika Saraswati

Vanderbilt University Medical Center

$927,158

Attributed

$1,019,394

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $304.7K · FY2017–24

$500K$375K$250K$125K$0

'17

'18

'19

'20

'21

'22

'23

'24

Funding mix

By agency

NIH$1,019,394 · 2

By mechanism

R01$896,413 · 1

R25$122,981 · 1

Top collaborators

Most similar at Vanderbilt University Medical Center

Same institution · by research overlap

Nicole Leanne Ward$14,066,442
Metin Nafi Gurcan$7,482,153
Fiona Edith Harrison$7,527,809
Seesandra Venkatappa Rajagopala$3,524,990
Elizabeth Heitman$57,592

Others in their field

Other Emerging Leaders on “Response”

Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$195,683,539
Kimberly Smith · Ppd Development Lp$115,671,664
Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
Kevin Urdahl · Seattle Children'S Hospital$84,741,409
Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
Ted Ross · University Of Georgia$70,992,558

Research focus

ResponseLightHealingFoundationsGenesGranulation TissueExtracellular MatrixCutaneousFibrosisCardiacAngiogenesisCell CommunicationCellsCharacteristicsCicatrixDepositionEquilibriumCollagen Type IBmp2 GeneAffectComplexConnective Tissue Growth FactorCostFibroblasts

Grant awards (5)

AGTC: Attaining Genomics Talent Cloud through Undergraduate Research Education$122,981

R25 · FY2024 · HG

Elucidating fibroblast heterogeneity as a pathway to target organ fibrosis$156,200

R01 · FY2019 · GM · contact PI

Elucidating fibroblast heterogeneity as a pathway to target organ fibrosis$130,871

R01 · FY2019 · GM · contact PI

Elucidating fibroblast heterogeneity as a pathway to target organ fibrosis$304,671

R01 · FY2018 · GM · contact PI

Elucidating fibroblast heterogeneity as a pathway to target organ fibrosis$304,671

R01 · FY2017 · GM · contact PI